Safety of low-density lipoprotein cholesterol reduction with atorvastatin versus simvastatin in a coronary heart disease population (the TARGET TANGIBLE Trial)
- 1 July 1999
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 84 (1) , 7-13
- https://doi.org/10.1016/s0002-9149(99)00183-6
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Comparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The CURVES Study) fn1fn1This study was supported by Parke-Davis, Division of Warner Lambert Company, Morris Plains, New Jersey. Manuscript received August 20, 1997; revised manuscript received and accepted November 24, 1997.The American Journal of Cardiology, 1998
- The Cost of Reaching National Cholesterol Education Program (NCEP) Goals in Hypercholesterolaemic PatientsPharmacoEconomics, 1998
- A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients witb hypercholesterolemiaThe American Journal of Cardiology, 1997
- When to Start Cholesterol-Lowering Therapy in Patients With Coronary Heart DiseaseCirculation, 1997
- Comparison of properties of four inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme a reductaseThe American Journal of Cardiology, 1994
- Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non‐zero risk difference or non‐unity relative riskStatistics in Medicine, 1990